The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia
This is my archive
Potential Benefits to Patients and Payers From Increased Measurement of Antipsychotic Plasma Levels in the Management of Schizophrenia
Simulated long-term outcomes of early use of long-acting injectable antipsychotics in early schizophrenia
The Role of Antipsychotic Plasma Levels in the Treatment of Schizophrenia
Improving Antipsychotic Adherence Among Patients With Schizophrenia: Savings for States
